Why fosfomycin trometamol as first line therapy for uncomplicated UTI?

• 1 October 2003
• journal article
• review article
• Published by Elsevier in International Journal of Antimicrobial Agents
• Vol. 22, 79-83
• https://doi.org/10.1016/s0924-8579(03)00231-0

Abstract

Keywords

• UNCOMPLICATED UTI
• RESISTANCE
• THERAPY
• FOSFOMYCIN TROMETAMOL
• ESCHERICHIA COLI
• TOXICITY
• URINARY TRACT
• BACTERIA
• ANTIBIOTIC RESISTANCE
• BIOLOGICAL ACTIVITY
• DRUG RESISTANCE
• INFECTIOUS DISEASE
• GENETIC MODIFICATION
• ANTIBIOTIC
• TREATMENT